Company Filing History:
Years Active: 2013
Title: R Anthony Shaw: Innovator in Immunoglobulin Disorder Diagnosis
Introduction
R Anthony Shaw is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of medical diagnostics, particularly in the identification of immunoglobulin disorders. His innovative approach utilizes advanced spectroscopic techniques to enhance diagnostic accuracy.
Latest Patents
R Anthony Shaw holds a patent for the "Identification of immunoglobulin (Ig) disorders using Fourier transform infrared spectroscopy." This patent describes a method and system for obtaining a serum mid-infrared spectroscopic profile using Fourier-transform infrared spectroscopy (FTIR). The method involves acquiring FTIR spectra for dried sera and preprocessing these spectra through differentiation and smoothing. This process enhances weak spectral features and removes baseline variations. The preprocessed FTIR spectra are then normalized to a common intensity range, focusing on the strongest infrared absorption for proteins. This innovative serum spectroscopic profile serves as a basis for diagnosing immunoglobulin disorders or quantifying serum immunoglobulin levels.
Career Highlights
Throughout his career, R Anthony Shaw has worked with esteemed institutions such as the University of Prince Edward Island and the National Research Council of Canada. His work has significantly impacted the field of immunology and diagnostics, showcasing his dedication to advancing medical technology.
Collaborations
R Anthony Shaw has collaborated with notable colleagues, including Christopher B Riley and J Trenton McClure. These partnerships have contributed to the development and refinement of his innovative diagnostic methods.
Conclusion
R Anthony Shaw's contributions to the field of immunoglobulin disorder diagnosis through his patented methods highlight his role as a leading inventor in medical technology. His work continues to influence the way immunological disorders are diagnosed and treated.